Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 8Carcinoma, Non-Small-Cell Lung 4Head and Neck Neoplasms 3Wilms Tumor 2Squamous Cell Carcinoma of Head and Neck 2Neurotoxicity Syndromes 2Lung Neoplasms 2Brain Neoplasms 2Untreated Childhood Medulloblastoma 1Tongue Neoplasms 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Intraductal Neoplasms 1Ototoxicity 1Oligodendroglioma 1Obesity 1Neurofibrosarcoma 1Malignant mesenchymal tumor 1Liposarcoma 1Leukemia, Myelomonocytic, Chronic 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Gliosarcoma 1

Interventions

Vincristine 3Cyclophosphamide 3Cisplatin 3Thiotepa 2Radiotherapy 2Methotrexate 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Carboplatin 2merphos 1Temozolomide 1Stem Cell Transplantation 1Radiotherapy, Conformal 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Leucovorin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Rhabdoid Tumor × Radiotherapy, Conformal × Clear all
NCT00653068 2024-04-23

Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System

Children's Oncology Group

Phase 3 Completed
70 enrolled 12 charts

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡